Pharmaron Beijing Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 3,757.160 million compared to CNY 2,908.123 million a year ago. Operating income was CNY 631.487 million compared to CNY 392.582 million a year ago. Net income was CNY 547.191 million compared to CNY 333.044 million a year ago. Basic earnings per share from continuing operations was CNY 0.8284 compared to CNY 0.5638 a year ago. Diluted earnings per share from continuing operations was CNY 0.8282 compared to CNY 0.5638 a year ago.